Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Mitchell Total Loss Data Q2 2017
The chart below illustrates the total loss data for both vehicle age and actual cash value of total loss vehicles processed through Mitchell server
Mitchell
Article
Consumer Self-Service Expectations are the New Normal
In 2016, smartphone ownership for individuals 13 years of age and older surpassed 81% in the United States, effectively reaching full market satura
Mitchell
Conference
RIMS 2018 Annual Conference & Exhibition
Visit Us at Booth #501 RIMS 2018 Annual Conference & Exhibition is the premier event for the risk management community.
Workers' Comp
White Paper
Help Combat Opioid Misuse
Best Practices and Partnerships We should start by recognizing the best methods to prevent overdose as well as to manage injured workers
Workers' Comp
Article
Resiliency in Irma’s Wake
“A dire threat.” “Likely to be far worse than the monster Andrew.”
Workers' Comp
Podcast